MARKET

SNCA

SNCA

Seneca Biopharma
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.5934
-0.0260
-4.20%
Closed 16:00 09/18 EDT
OPEN
0.6140
PREV CLOSE
0.6194
HIGH
0.6192
LOW
0.5930
VOLUME
242.40K
TURNOVER
--
52 WEEK HIGH
4.090
52 WEEK LOW
0.5000
MARKET CAP
10.26M
P/E (TTM)
-0.2828
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile

Analyst Price Target

The average SNCA stock price target is 26.00 with a high estimate of 26.00 and a low estimate of 26.00.

Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About SNCA
Seneca Biopharma, Inc., formerly Neuralstem, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing treatments for diseases of unmet medical need. It is focused on finding and acquiring new assets, sciences and technologies that provide therapies for patients. It intends to focus on developing a pipeline of biopharmaceuticals and commercializing those products.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of Seneca Biopharma Inc stock information, including NASDAQ:SNCA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SNCA stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading SNCA stock methods without spending real money on the virtual paper trading platform.